Why Choose Private Prescription for Weight Management?
Difference Between Mounjaro and Wegovy: Private vs NHS Route
The key difference between Mounjaro and Wegovy access lies in choosing private prescription over the NHS pathway. NHS patients face GP referrals to specialist weight management services, strict BMI criteria, and waiting lists exceeding 6 months in many areas. Private prescription eliminates these barriers entirely. EverydayMeds provides both Wegovy (semaglutide) and guidance on the difference between Mounjaro and Wegovy through direct clinical assessment, with prescriber review typically completed within 24-72 hours.
Both medications require the same clinical considerations – BMI ≥30 or BMI ≥27 with comorbidities, alongside a reduced-calorie diet and increased physical activity. The difference between Mounjaro and Wegovy mechanisms means your prescriber will evaluate which suits your individual circumstances. Private prescription ensures you receive genuine medication from our GPhC-registered pharmacy (#9012878), with the same safety standards as NHS supply but without institutional delays.
Wegovy Pricing and Value Through Private Prescription
Understanding the difference between Mounjaro and Wegovy costs helps inform your treatment choice. Wegovy pricing starts at £79.99 for the 0.25mg starter dose (weeks 1-4) when using code FIRST40 for new customers. The dose escalation continues with 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, and maintenance 2.4mg at £209.99. Bundle options like the Intro Duo (0.25mg & 0.5mg) cost £169.99, providing your first two months of treatment in one convenient order.
Returning customers benefit from the DOSE25 discount code applied at checkout. The difference between Mounjaro and Wegovy pricing structures reflects their different manufacturers and patent positions. Both medications require prescription-only medicine status, ensuring clinical oversight throughout treatment. Our Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, eliminating the need for monthly reordering once you reach your optimal dose.
Clinical Evidence: Difference Between Mounjaro and Wegovy Mechanisms
The primary difference between Mounjaro and Wegovy lies in their receptor targets. Wegovy (semaglutide) acts as a GLP-1 receptor agonist, mimicking the natural incretin hormone that regulates appetite and glucose metabolism. In the STEP trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021).
Mounjaro (tirzepatide) represents a dual approach, targeting both GLP-1 and GIP receptors simultaneously. This difference between Mounjaro and Wegovy mechanisms may influence individual response patterns, though direct head-to-head comparison data remains limited due to different trial designs and populations. Both medications are available from EverydayMeds, and your prescriber can help determine which mechanism suits your clinical profile.
How Wegovy Works: GLP-1 Receptor Mechanism
Wegovy functions as a GLP-1 receptor agonist, mimicking glucagon-like peptide-1, a natural hormone released when food enters your digestive system. This mechanism reduces appetite by acting on brain centres that control hunger and satiety, promoting feelings of fullness after smaller meals. The medication may also reduce food cravings and slow gastric emptying, helping maintain satisfaction between meals. Unlike simple appetite suppressants, Wegovy works through multiple pathways to support sustainable weight management. This prescription-only medicine requires clinical assessment to ensure appropriate use alongside lifestyle modifications for optimal effectiveness.
Ordering Process: Private Prescription Made Simple
The difference between Mounjaro and Wegovy access through EverydayMeds begins with our streamlined 3-minute online clinical assessment, covering medical history, current medications, and weight management goals. Our qualified prescribers review applications within standard 3 working days, or 24 hours with express service. Once approved, medications ship via next-day delivery using temperature-controlled cold-chain logistics to maintain pharmaceutical integrity. No GP referral is required, eliminating the traditional barrier between you and effective weight management treatment. Payment processing includes automatic application of discount codes FIRST40 (new customers) or DOSE25 (returning customers) at checkout for transparent final pricing.
Storage and Practical Considerations
A practical difference between Mounjaro and Wegovy involves storage requirements and travel convenience. Wegovy maintains stability for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day limit. Both medications require initial storage at 2-8°C and use pre-filled FlexTouch pen systems for once-weekly injection. Wegovy follows mandatory dose escalation: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance from week 17 onwards. This gradual increase minimises gastrointestinal side effects while establishing therapeutic effectiveness.
Difference Between Mounjaro and Wegovy: UK Regulatory Status
Both Wegovy and Mounjaro hold MHRA marketing authorisation for weight management in adults with BMI ≥30, or BMI ≥27 with weight-related comorbidities. The difference between Mounjaro and Wegovy regulatory pathways reflects their distinct active compounds and manufacturer submissions. Wegovy carries Black Triangle (▼) status, indicating additional MHRA monitoring as part of ongoing pharmacovigilance. This enhanced oversight ensures continued safety evaluation as real-world usage data accumulates.
NICE guidance TA875 recommends Wegovy alongside specialist weight management support, though private prescription allows direct access without specialist referral delays. The difference between Mounjaro and Wegovy NICE evaluations continues evolving as health technology assessments progress. EverydayMeds ensures both treatments meet identical clinical governance standards through our GPhC-registered pharmacy operations.
Complete Your Assessment Today
The difference between Mounjaro and Wegovy becomes clearer through professional clinical assessment tailored to your individual circumstances. EverydayMeds eliminates NHS waiting times while maintaining identical safety standards for these prescription-only medicines. New customers use code FIRST40 at checkout, while returning customers apply DOSE25 for transparent final pricing. Our qualified prescribers evaluate your medical history, weight management goals, and any contraindications to determine optimal treatment selection. Start your 3-minute assessment at https://everydaymeds.co.uk/collections/wegovy and receive expert guidance on choosing between these evidence-based weight management options.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
